ArticleFrontiers in immunology2025

A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy.

Yinmei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.